These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 32384093)
1. Predicting cancer origins with a DNA methylation-based deep neural network model. Zheng C; Xu R PLoS One; 2020; 15(5):e0226461. PubMed ID: 32384093 [TBL] [Abstract][Full Text] [Related]
2. Image-based deep learning model using DNA methylation data predicts the origin of cancer of unknown primary. Hwang J; Lee Y; Yoo SK; Kim JI Neoplasia; 2024 Sep; 55():101021. PubMed ID: 38943996 [TBL] [Abstract][Full Text] [Related]
3. A Linear Regression and Deep Learning Approach for Detecting Reliable Genetic Alterations in Cancer Using DNA Methylation and Gene Expression Data. Mallik S; Seth S; Bhadra T; Zhao Z Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806782 [TBL] [Abstract][Full Text] [Related]
4. Accurate prediction of pan-cancer types using machine learning with minimal number of DNA methylation sites. Ning W; Wu T; Wu C; Wang S; Tao Z; Wang G; Zhao X; Diao K; Wang J; Chen J; Chen F; Liu XS J Mol Cell Biol; 2023 Aug; 15(4):. PubMed ID: 37037781 [TBL] [Abstract][Full Text] [Related]
5. DNA Methylation Markers for Pan-Cancer Prediction by Deep Learning. Liu B; Liu Y; Pan X; Li M; Yang S; Li SC Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31590287 [TBL] [Abstract][Full Text] [Related]
6. A hybrid metaheuristic-deep learning technique for the pan-classification of cancer based on DNA methylation. Eissa NS; Khairuddin U; Yusof R BMC Bioinformatics; 2022 Jul; 23(1):273. PubMed ID: 35818034 [TBL] [Abstract][Full Text] [Related]
7. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC). Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239 [TBL] [Abstract][Full Text] [Related]
8. Minimalist approaches to cancer tissue-of-origin classification by DNA methylation. Xia D; Leon AJ; Cabanero M; Pugh TJ; Tsao MS; Rath P; Siu LL; Yu C; Bedard PL; Shepherd FA; Zadeh G; Chetty R; Aldape K Mod Pathol; 2020 Oct; 33(10):1874-1888. PubMed ID: 32415265 [TBL] [Abstract][Full Text] [Related]
9. Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin. Liu H; Qiu C; Wang B; Bing P; Tian G; Zhang X; Ma J; He B; Yang J Front Cell Dev Biol; 2021; 9():619330. PubMed ID: 34012960 [TBL] [Abstract][Full Text] [Related]
10. Deep learning and machine learning approaches to classify stomach distant metastatic tumors using DNA methylation profiles. Shi J; Chen Y; Wang Y Comput Biol Med; 2024 Jun; 175():108496. PubMed ID: 38657466 [TBL] [Abstract][Full Text] [Related]
11. Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis. Ding W; Chen G; Shi T Epigenetics; 2019 Jan; 14(1):67-80. PubMed ID: 30696380 [TBL] [Abstract][Full Text] [Related]
12. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma. Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686 [TBL] [Abstract][Full Text] [Related]
13. Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of origin. Shimizu D; Taniue K; Matsui Y; Haeno H; Araki H; Miura F; Fukunaga M; Shiraishi K; Miyamoto Y; Tsukamoto S; Komine A; Kobayashi Y; Kitagawa A; Yoshikawa Y; Sato K; Saito T; Ito S; Masuda T; Niida A; Suzuki M; Baba H; Ito T; Akimitsu N; Kodera Y; Mimori K Cancer Gene Ther; 2022 May; 29(5):428-436. PubMed ID: 34744163 [TBL] [Abstract][Full Text] [Related]
14. Tissue of origin prediction for cancer of unknown primary using a targeted methylation sequencing panel. Sun M; Xu B; Chen C; Zhu Y; Li X; Chen K Clin Epigenetics; 2024 Feb; 16(1):25. PubMed ID: 38336771 [TBL] [Abstract][Full Text] [Related]
15. Urine cell-based DNA methylation classifier for monitoring bladder cancer. van der Heijden AG; Mengual L; Ingelmo-Torres M; Lozano JJ; van Rijt-van de Westerlo CCM; Baixauli M; Geavlete B; Moldoveanud C; Ene C; Dinney CP; Czerniak B; Schalken JA; Kiemeney LALM; Ribal MJ; Witjes JA; Alcaraz A Clin Epigenetics; 2018; 10():71. PubMed ID: 29854012 [TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers. Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370 [TBL] [Abstract][Full Text] [Related]
17. Circulating tumor DNA Sun X; Li H; Sun M; Yuan Y; Sun L Future Oncol; 2019 Oct; 15(30):3513-3525. PubMed ID: 31578881 [No Abstract] [Full Text] [Related]
18. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel. Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387 [TBL] [Abstract][Full Text] [Related]
19. Hierarchical classification-based pan-cancer methylation analysis to classify primary cancer. Yang Y; Zeng Q; Liu G; Zheng S; Luo T; Guo Y; Tang J; Huang Y BMC Bioinformatics; 2023 Dec; 24(1):465. PubMed ID: 38066424 [TBL] [Abstract][Full Text] [Related]
20. Identification of Specific Candidate Diagnostic Biomarkers for Lung Squamous Cell Carcinoma Based on Methylation. Wang X; Wang X; Li X; Chang Y J Comput Biol; 2020 May; 27(5):825-833. PubMed ID: 31486674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]